SARS-CoV-2: A potential trigger of dermato-neuro syndrome in a patient with scleromyxedema

• Mike Fritz, BS,
• Daniel Tinker, MD,
• Alex W. Wessel, BS,
• Gabriela M. Morris, MD,
• Linda Goldenberg, MSN, RN,
• Mark Fesler, MD,
• Lokesh Rukmangadachar, MD, MS,
• M. Yadira Hurley, MD

Affiliations

Mike Fritz, BS

University of Kentucky College of Medicine, Lexington, Kentucky; Correspondence to: Mike Fritz, BS, University of Kentucky College of Medicine, MN Building Room 150, 800 Rose Street, Lexington, KY 40506.

Daniel Tinker, MD

Department of Dermatology, Saint Louis University, St. Louis, Missouri

Alex W. Wessel, BS

Washington University School of Medicine, St. Louis, Missouri

Gabriela M. Morris, MD

Department of Dermatology, Saint Louis University, St. Louis, Missouri

Linda Goldenberg, MSN, RN

Division of Hematology, Oncology, & Cellular Therapy, Department of Internal Medicine, Saint Louis University, St. Louis, Missouri

Mark Fesler, MD

Division of Hematology, Oncology, & Cellular Therapy, Department of Internal Medicine, Saint Louis University, St. Louis, Missouri

Lokesh Rukmangadachar, MD, MS

Department of Neurology, Saint Louis University, St. Louis, Missouri

M. Yadira Hurley, MD

Department of Dermatology, Saint Louis University, St. Louis, Missouri